The impact of locoregional treatments for metastatic castration resistant prostate cancer on disease progression: real life experience from a multicenter cohort.
Ferriero M, Prata F, Mastroianni R, De Nunzio C, Tema G, Tuderti G, Bove AM, Anceschi U, Brassetti A, Misuraca L, Giacinti S, Calabrò F, Guaglianone S, Tubaro A, Papalia R, Leonardo C, Gallucci M, Simone G.
Ferriero M, et al. Among authors: leonardo c.
Prostate Cancer Prostatic Dis. 2024 Mar;27(1):89-94. doi: 10.1038/s41391-022-00623-5. Epub 2022 Dec 2.
Prostate Cancer Prostatic Dis. 2024.
PMID: 36460734